Clinical Trial Update: Disease Burden and Biology Using Tumor Cell Free DNA in Metastatic Kidney Cancer

View source ↗

Summary

A completed clinical trial evaluating disease burden and tumor biology in metastatic renal cell carcinoma using tumor cell free DNA.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Vanderbilt-Ingram Cancer Center | Conditions: Renal Cell Carcinoma | Status: COMPLETED